Literature DB >> 20133599

Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy.

Yuko Fukata1, Kathryn L Lovero, Tsuyoshi Iwanaga, Atsushi Watanabe, Norihiko Yokoi, Katsuhiko Tabuchi, Ryuichi Shigemoto, Roger A Nicoll, Masaki Fukata.   

Abstract

Epilepsy is a devastating and poorly understood disease. Mutations in a secreted neuronal protein, leucine-rich glioma inactivated 1 (LGI1), were reported in patients with an inherited form of human epilepsy, autosomal dominant partial epilepsy with auditory features (ADPEAF). Here, we report an essential role of LGI1 as an antiepileptogenic ligand. We find that loss of LGI1 in mice (LGI1(-/-)) causes lethal epilepsy, which is specifically rescued by the neuronal expression of LGI1 transgene, but not LGI3. Moreover, heterozygous mice for the LGI1 mutation (LGI1(+/-)) show lowered seizure thresholds. Extracellularly secreted LGI1 links two epilepsy-related receptors, ADAM22 and ADAM23, in the brain and organizes a transsynaptic protein complex that includes presynaptic potassium channels and postsynaptic AMPA receptor scaffolds. A lack of LGI1 disrupts this synaptic protein connection and selectively reduces AMPA receptor-mediated synaptic transmission in the hippocampus. Thus, LGI1 may serve as a major determinant of brain excitation, and the LGI1 gene-targeted mouse provides a good model for human epilepsy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133599      PMCID: PMC2840530          DOI: 10.1073/pnas.0914537107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Efficient ADAM22 surface expression is mediated by phosphorylation-dependent interaction with 14-3-3 protein family members.

Authors:  Nathan J Gödde; Giovanna M D'Abaco; Lucy Paradiso; Ulrike Novak
Journal:  J Cell Sci       Date:  2006-07-25       Impact factor: 5.285

2.  Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission.

Authors:  Yuko Fukata; Hillel Adesnik; Tsuyoshi Iwanaga; David S Bredt; Roger A Nicoll; Masaki Fukata
Journal:  Science       Date:  2006-09-22       Impact factor: 47.728

3.  ADPEAF mutations reduce levels of secreted LGI1, a putative tumor suppressor protein linked to epilepsy.

Authors:  Kristen R Senechal; Christina Thaller; Jeffrey L Noebels
Journal:  Hum Mol Genet       Date:  2005-04-27       Impact factor: 6.150

4.  Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy.

Authors:  Yu-Dong Zhou; Sanghoon Lee; Zhe Jin; Moriah Wright; Stephen E P Smith; Matthew P Anderson
Journal:  Nat Med       Date:  2009-08-23       Impact factor: 53.440

5.  Loss of inhibitory neuron AMPA receptors contributes to ataxia and epilepsy in stargazer mice.

Authors:  Karen Menuz; Roger A Nicoll
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

6.  LGI1-associated epilepsy through altered ADAM23-dependent neuronal morphology.

Authors:  Katherine Owuor; Noam Y Harel; Dario J Englot; Fuki Hisama; Hal Blumenfeld; Stephen M Strittmatter
Journal:  Mol Cell Neurosci       Date:  2009-09-29       Impact factor: 4.314

7.  Seizures and reduced life span in mice lacking the potassium channel subunit Kv1.2, but hypoexcitability and enlarged Kv1 currents in auditory neurons.

Authors:  Helen M Brew; Joshua X Gittelman; Robert S Silverstein; Timothy D Hanks; Vas P Demas; Linda C Robinson; Carol A Robbins; Jennifer McKee-Johnson; Shing Yan Chiu; Albee Messing; Bruce L Tempel
Journal:  J Neurophysiol       Date:  2007-07-18       Impact factor: 2.714

Review 8.  LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy.

Authors:  Carlo Nobile; Roberto Michelucci; Simonetta Andreazza; Elena Pasini; Silvio C E Tosatto; Pasquale Striano
Journal:  Hum Mutat       Date:  2009-04       Impact factor: 4.878

9.  Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice.

Authors:  Koji Sagane; Kazuhiro Hayakawa; Junko Kai; Tomoko Hirohashi; Eiki Takahashi; Norimasa Miyamoto; Mitsuhiro Ino; Tohru Oki; Kazuto Yamazaki; Takeshi Nagasu
Journal:  BMC Neurosci       Date:  2005-05-06       Impact factor: 3.288

10.  LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11.

Authors:  Koji Sagane; Yasushi Ishihama; Hachiro Sugimoto
Journal:  Int J Biol Sci       Date:  2008-10-21       Impact factor: 6.580

View more
  101 in total

1.  Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.

Authors:  Meizan Lai; Maartje G M Huijbers; Eric Lancaster; Francesc Graus; Luis Bataller; Rita Balice-Gordon; John K Cowell; Josep Dalmau
Journal:  Lancet Neurol       Date:  2010-06-28       Impact factor: 44.182

2.  Pearls & Oy-sters: Limbic encephalitis associated with positive anti-LGI1 and antithyroid antibodies.

Authors:  Sheng-Jun Wang; Yu-Ying Zhao; Qin-Zhou Wang; Bin Guo; Yi-Ming Liu; Chuan-Zhu Yan
Journal:  Neurology       Date:  2016-01-12       Impact factor: 9.910

Review 3.  Neuronal central nervous system syndromes probably mediated by autoantibodies.

Authors:  Aude Chefdeville; Jérôme Honnorat; Christiane S Hampe; Virginie Desestret
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

4.  The LGI1-ADAM22 protein complex directs synapse maturation through regulation of PSD-95 function.

Authors:  Kathryn L Lovero; Yuko Fukata; Adam J Granger; Masaki Fukata; Roger A Nicoll
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-15       Impact factor: 11.205

5.  Domain integration of ADAM family proteins: Emerging themes from structural studies.

Authors:  Tom Cm Seegar; Stephen C Blacklow
Journal:  Exp Biol Med (Maywood)       Date:  2019-07-23

Review 6.  Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.

Authors:  Josep Dalmau; Christian Geis; Francesc Graus
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

7.  Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients.

Authors:  Romana Höftberger; Agnes van Sonderen; Frank Leypoldt; David Houghton; Michael Geschwind; Jeffrey Gelfand; Mercedes Paredes; Lidia Sabater; Albert Saiz; Maarten J Titulaer; Francesc Graus; Josep Dalmau
Journal:  Neurology       Date:  2015-05-15       Impact factor: 9.910

8.  Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy.

Authors:  Norihiko Yokoi; Yuko Fukata; Daisuke Kase; Taisuke Miyazaki; Martine Jaegle; Toshika Ohkawa; Naoki Takahashi; Hiroko Iwanari; Yasuhiro Mochizuki; Takao Hamakubo; Keiji Imoto; Dies Meijer; Masahiko Watanabe; Masaki Fukata
Journal:  Nat Med       Date:  2014-12-08       Impact factor: 53.440

9.  Expression of NgR1-antagonizing proteins decreases with aging and cognitive decline in rat hippocampus.

Authors:  Heather D VanGuilder Starkey; Georgina V Bixler; William E Sonntag; Willard M Freeman
Journal:  Cell Mol Neurobiol       Date:  2013-03-24       Impact factor: 5.046

10.  A computational model of the LGI1 protein suggests a common binding site for ADAM proteins.

Authors:  Emanuela Leonardi; Simonetta Andreazza; Stefano Vanin; Giorgia Busolin; Carlo Nobile; Silvio C E Tosatto
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.